1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor
Chockalingam, P. S. ; Sun, W. ; Rivera-Bermudez, M. A. ; Zeng, W. ; Dufield, D. R. ; Larsson, Staffan LU
; Lohmander, Stefan
LU
; Flannery, C. R.
; Glasson, S. S.
and Georgiadis, K. E.
, et al.
(2011)
In Osteoarthritis and Cartilage
19(3).
p.315-323
- Contribution to journal › Article
- 2010
-
Mark
Aggrecan fragments as biomarkers in osteoarthritis
Larsson, Staffan LU
(2010)
In Lund University Faculty of Medicine Doctoral Dissertation Series
2010:55.
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments
Pratta, M. A. ; Su, J. L. ; Leesnitzer, M. A. ; Struglics, André LU ; Larsson, Staffan LU
; Lohmander, Stefan
LU
and Kumar, S.
(2006)
In Osteoarthritis and Cartilage
14(7).
p.702-713
- Contribution to journal › Article
-
Mark
Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics, André LU ; Larsson, Staffan LU
; Pratta, M A
; Kumar, S
; Lark, M W
and Lohmander, Stefan
LU
(2006)
In Osteoarthritis and Cartilage
14(2).
p.101-113
- Contribution to journal › Article
- 2003
-
Mark
Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs
- Contribution to journal › Article
- 1997
-
Mark
Aggrecan degradation in human cartilage : Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints
- Contribution to journal › Article